GlassScriptPhysician profile
Michael J Labanowski
NPI 1225086366
$3,414.43
in general payments reported to CMS, 2019-2025
15 companies · $40.04 in 2025
The $40.04 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $380 · 2021: $690 · 2022: $670 · 2023: $992 · 2024: $479 · 2025: $40.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.36 |
| Education | $146.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,324.60 | 2019-2024 | |
| Harmony Biosciences LLC | $600.70 | 2020-2024 | Wakix |
| Merck Sharp & Dohme LLC | $396.68 | 2020-2023 | Belsomra |
| Axsome Therapeutics, INC. | $231.99 | 2023-2024 | Sunosi |
| Idorsia Pharmaceuticals US INC | $227.22 | 2022-2024 | Quviviq |
| Eisai INC. | $201.52 | 2020-2022 | |
| Inspire Medical Systems, INC. | $141.92 | 2023-2024 | Inspire |
| Lilly USA, LLC | $78.37 | 2019-2025 | Zepbound |
| Arbor Pharmaceuticals, INC. | $45.48 | 2019-2020 | |
| Amgen INC. | $35.72 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $34.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.48 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $24.52 | 2021 | |
| Almatica Pharma LLC | $24.04 | 2023 | Gralise |
| Novartis Pharmaceuticals Corporation | $22.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Labanowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.